Answers are grounded in this paper and cite their sources.
Positron emission tomography/computed tomography (PET/CT) is a metabolic imaging method that enables quantitative measurements.This diagnostic method has been used for the evaluation of oncologic patients for many years.Because of the limitations of sectional radiological diagnostic methods during therapy response assessment after chemotherapy or radiotherapy, the use of PET/CT for this indication has increased in the last years.Particularly, early therapy response evaluation has gained special attention after the increased use of neoadjuvant therapies.In this review, we aimed to evaluate the role of PET/CT in the evaluation of therapy response in thoracic malignancies, particularly in lung and esophageal cancers, in light of the recent literature.
No takes yet. Share an insight, caveat, or question.
Özkan et al. (2015) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: